Moderna and Pfizer have previously announced that the updated vaccines would be ready this fall. The FDA’s approval comes amid a steady rise in reported COVID-19 cases and hospitalizations in ...

In a widely anticipated move, and following several countries’ earlier approval, the Food and Drug Administration approved the use of Pfizer and Moderna booster shots today, for certain ...

Pfizer (PFE) shares traded higher Thursday after the U.S. Food & Drug Administration formally approved its coronavirus vaccine for booster shots in older and at risk Americans. The FDA said ...

The FDA and Pfizer had originally proposed approving ... The White House in August signaled that it intended to sanction booster shots for all Americans in the week of Sept. 20.

The FDA says it examined safety and immunogenicity data from a clinical study before authorizing the bivalent shots. In studying Pfizer’s new booster, 600 adults 55 and older received a single ...

17, the FDA’s outside advisory committee is due to publicly review Pfizer’s data supporting ... to see more data before encouraging third booster shots for the general population starting ...

The FDA and CDC fully authorized Pfizer’s booster shot in late September ... a “mix and match” approach to COVID vaccine booster shots this week when they give full approval for Moderna ...

For everyone else, there's no new booster recommendation for now, though the FDA and CDC ... moving forward. Pfizer also said it will have a patient assistance program to keep shots free for ...

The new vaccines, developed by Moderna and Pfizer-BioNTech ... Preliminary data show that this booster will trigger the production of antibodies that recognize this form of SARS-CoV-2.

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

The FDA has authorised updated ... 5, and Moderna has indicated that its booster also works against FL.1.51. Meanwhile, Moderna and Pfizer/BioNTech have also said their shots seem to provide ...

US pharmaceutical company Pfizer has filed ... Drug Administration (FDA) this week for an emergency clearance to vaccinate children aged 5 to 11 with a 10-microgram booster dose against the ...